nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefixime—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.0045	0.0045	CcSEcCtD
Cefixime—Erythema multiforme—Tamoxifen—pancreatic cancer	0.0045	0.0045	CcSEcCtD
Cefixime—Renal failure—Sunitinib—pancreatic cancer	0.00447	0.00447	CcSEcCtD
Cefixime—Erythema multiforme—Erlotinib—pancreatic cancer	0.00446	0.00446	CcSEcCtD
Cefixime—Colitis—Docetaxel—pancreatic cancer	0.00444	0.00444	CcSEcCtD
Cefixime—Urinary tract infection—Sunitinib—pancreatic cancer	0.00442	0.00442	CcSEcCtD
Cefixime—Candida infection—Docetaxel—pancreatic cancer	0.00442	0.00442	CcSEcCtD
Cefixime—Blister—Epirubicin—pancreatic cancer	0.00433	0.00433	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00426	0.00426	CcSEcCtD
Cefixime—Haemoglobin—Sunitinib—pancreatic cancer	0.0041	0.0041	CcSEcCtD
Cefixime—Haemorrhage—Sunitinib—pancreatic cancer	0.00408	0.00408	CcSEcCtD
Cefixime—Hepatitis—Sunitinib—pancreatic cancer	0.00408	0.00408	CcSEcCtD
Cefixime—Flatulence—Erlotinib—pancreatic cancer	0.00404	0.00404	CcSEcCtD
Cefixime—Blister—Doxorubicin—pancreatic cancer	0.004	0.004	CcSEcCtD
Cefixime—Eosinophilia—Fluorouracil—pancreatic cancer	0.00398	0.00398	CcSEcCtD
Cefixime—Neutropenia—Irinotecan—pancreatic cancer	0.00393	0.00393	CcSEcCtD
Cefixime—Pancytopenia—Gemcitabine—pancreatic cancer	0.00388	0.00388	CcSEcCtD
Cefixime—Erythema multiforme—Sunitinib—pancreatic cancer	0.00386	0.00386	CcSEcCtD
Cefixime—Neutropenia—Gemcitabine—pancreatic cancer	0.00382	0.00382	CcSEcCtD
Cefixime—Pancytopenia—Fluorouracil—pancreatic cancer	0.00382	0.00382	CcSEcCtD
Cefixime—Angioedema—Tamoxifen—pancreatic cancer	0.00379	0.00379	CcSEcCtD
Cefixime—Leukopenia—Tamoxifen—pancreatic cancer	0.00371	0.00371	CcSEcCtD
Cefixime—Renal failure—Irinotecan—pancreatic cancer	0.00368	0.00368	CcSEcCtD
Cefixime—Jaundice—Irinotecan—pancreatic cancer	0.00365	0.00365	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00361	0.00361	CcSEcCtD
Cefixime—Renal failure—Gemcitabine—pancreatic cancer	0.00358	0.00358	CcSEcCtD
Cefixime—Renal impairment—Docetaxel—pancreatic cancer	0.00353	0.00353	CcSEcCtD
Cefixime—Dermatitis bullous—Docetaxel—pancreatic cancer	0.00351	0.00351	CcSEcCtD
Cefixime—Flatulence—Sunitinib—pancreatic cancer	0.0035	0.0035	CcSEcCtD
Cefixime—Urinary tract infection—Fluorouracil—pancreatic cancer	0.00348	0.00348	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Epirubicin—pancreatic cancer	0.00343	0.00343	CcSEcCtD
Cefixime—Agranulocytosis—Gemcitabine—pancreatic cancer	0.0034	0.0034	CcSEcCtD
Cefixime—Haemoglobin—Irinotecan—pancreatic cancer	0.00338	0.00338	CcSEcCtD
Cefixime—Haemorrhage—Irinotecan—pancreatic cancer	0.00336	0.00336	CcSEcCtD
Cefixime—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Cefixime—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00331	0.00331	CcSEcCtD
Cefixime—Blood bilirubin increased—Epirubicin—pancreatic cancer	0.0033	0.0033	CcSEcCtD
Cefixime—Shock—Erlotinib—pancreatic cancer	0.00329	0.00329	CcSEcCtD
Cefixime—Haemoglobin—Gemcitabine—pancreatic cancer	0.00329	0.00329	CcSEcCtD
Cefixime—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00328	0.00328	CcSEcCtD
Cefixime—Haemorrhage—Gemcitabine—pancreatic cancer	0.00327	0.00327	CcSEcCtD
Cefixime—Angioedema—Sunitinib—pancreatic cancer	0.00324	0.00324	CcSEcCtD
Cefixime—Haemoglobin—Fluorouracil—pancreatic cancer	0.00323	0.00323	CcSEcCtD
Cefixime—Haemorrhage—Fluorouracil—pancreatic cancer	0.00322	0.00322	CcSEcCtD
Cefixime—Leukopenia—Sunitinib—pancreatic cancer	0.00318	0.00318	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Doxorubicin—pancreatic cancer	0.00317	0.00317	CcSEcCtD
Cefixime—Vaginal inflammation—Epirubicin—pancreatic cancer	0.00312	0.00312	CcSEcCtD
Cefixime—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00309	0.00309	CcSEcCtD
Cefixime—Convulsion—Sunitinib—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Cefixime—Blood bilirubin increased—Doxorubicin—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.00302	0.00302	CcSEcCtD
Cefixime—Colitis—Epirubicin—pancreatic cancer	0.003	0.003	CcSEcCtD
Cefixime—Candida infection—Epirubicin—pancreatic cancer	0.00298	0.00298	CcSEcCtD
Cefixime—Dyspepsia—Tamoxifen—pancreatic cancer	0.00298	0.00298	CcSEcCtD
Cefixime—Dyspepsia—Erlotinib—pancreatic cancer	0.00295	0.00295	CcSEcCtD
Cefixime—Vaginal infection—Epirubicin—pancreatic cancer	0.00295	0.00295	CcSEcCtD
Cefixime—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Cefixime—Vaginal inflammation—Doxorubicin—pancreatic cancer	0.00289	0.00289	CcSEcCtD
Cefixime—Flatulence—Irinotecan—pancreatic cancer	0.00288	0.00288	CcSEcCtD
Cefixime—Shock—Sunitinib—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Cefixime—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00284	0.00284	CcSEcCtD
Cefixime—Colitis—Doxorubicin—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Cefixime—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Cefixime—Candida infection—Doxorubicin—pancreatic cancer	0.00276	0.00276	CcSEcCtD
Cefixime—Pancytopenia—Docetaxel—pancreatic cancer	0.00276	0.00276	CcSEcCtD
Cefixime—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00274	0.00274	CcSEcCtD
Cefixime—Vaginal infection—Doxorubicin—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Cefixime—Neutropenia—Docetaxel—pancreatic cancer	0.00271	0.00271	CcSEcCtD
Cefixime—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00271	0.00271	CcSEcCtD
Cefixime—Urticaria—Tamoxifen—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Cefixime—Abdominal pain—Tamoxifen—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Cefixime—Abdominal pain—Erlotinib—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Cefixime—Body temperature increased—Erlotinib—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Cefixime—Leukopenia—Irinotecan—pancreatic cancer	0.00262	0.00262	CcSEcCtD
Cefixime—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.00259	0.00259	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00257	0.00257	CcSEcCtD
Cefixime—Dyspepsia—Sunitinib—pancreatic cancer	0.00255	0.00255	CcSEcCtD
Cefixime—Leukopenia—Gemcitabine—pancreatic cancer	0.00255	0.00255	CcSEcCtD
Cefixime—Renal failure—Docetaxel—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Cefixime—Jaundice—Docetaxel—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Cefixime—Leukopenia—Fluorouracil—pancreatic cancer	0.00251	0.00251	CcSEcCtD
Cefixime—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Cefixime—Renal failure acute—Epirubicin—pancreatic cancer	0.00245	0.00245	CcSEcCtD
Cefixime—Convulsion—Fluorouracil—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Cefixime—Agranulocytosis—Docetaxel—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Cefixime—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.0024	0.0024	CcSEcCtD
Cefixime—Pruritus—Tamoxifen—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Cefixime—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Cefixime—Renal impairment—Epirubicin—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Cefixime—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Cefixime—Dermatitis bullous—Epirubicin—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Cefixime—Pruritus—Erlotinib—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Cefixime—Shock—Irinotecan—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Cefixime—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00234	0.00234	CcSEcCtD
Cefixime—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00234	0.00234	CcSEcCtD
Cefixime—Haemoglobin—Docetaxel—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Cefixime—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Cefixime—Haemorrhage—Docetaxel—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Cefixime—Hepatitis—Docetaxel—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Cefixime—Diarrhoea—Tamoxifen—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Cefixime—Abdominal pain—Sunitinib—pancreatic cancer	0.00229	0.00229	CcSEcCtD
Cefixime—Body temperature increased—Sunitinib—pancreatic cancer	0.00229	0.00229	CcSEcCtD
Cefixime—Diarrhoea—Erlotinib—pancreatic cancer	0.00229	0.00229	CcSEcCtD
Cefixime—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00229	0.00229	CcSEcCtD
Cefixime—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Cefixime—Renal failure acute—Doxorubicin—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Cefixime—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Cefixime—Dizziness—Tamoxifen—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Cefixime—Dizziness—Erlotinib—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Cefixime—Renal impairment—Doxorubicin—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Cefixime—Erythema multiforme—Docetaxel—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Cefixime—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Cefixime—Face oedema—Epirubicin—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Cefixime—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Cefixime—Vomiting—Tamoxifen—pancreatic cancer	0.00215	0.00215	CcSEcCtD
Cefixime—Hypersensitivity—Sunitinib—pancreatic cancer	0.00214	0.00214	CcSEcCtD
Cefixime—Rash—Tamoxifen—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Cefixime—Dermatitis—Tamoxifen—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Cefixime—Vomiting—Erlotinib—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Cefixime—Headache—Tamoxifen—pancreatic cancer	0.00212	0.00212	CcSEcCtD
Cefixime—Rash—Erlotinib—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Cefixime—Dermatitis—Erlotinib—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Cefixime—Dyspepsia—Irinotecan—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Cefixime—Headache—Erlotinib—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Cefixime—Pruritus—Sunitinib—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Cefixime—Face oedema—Doxorubicin—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Cefixime—Dyspepsia—Fluorouracil—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Cefixime—Nausea—Tamoxifen—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Cefixime—Nausea—Erlotinib—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Cefixime—Diarrhoea—Sunitinib—pancreatic cancer	0.00198	0.00198	CcSEcCtD
Cefixime—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00195	0.00195	CcSEcCtD
Cefixime—Eosinophilia—Epirubicin—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Cefixime—Dizziness—Sunitinib—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Cefixime—Abdominal pain—Irinotecan—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Cefixime—Body temperature increased—Irinotecan—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Cefixime—Pancytopenia—Epirubicin—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Cefixime—Vomiting—Sunitinib—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Cefixime—Body temperature increased—Gemcitabine—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Cefixime—Neutropenia—Epirubicin—pancreatic cancer	0.00183	0.00183	CcSEcCtD
Cefixime—Rash—Sunitinib—pancreatic cancer	0.00183	0.00183	CcSEcCtD
Cefixime—Dermatitis—Sunitinib—pancreatic cancer	0.00183	0.00183	CcSEcCtD
Cefixime—Urticaria—Fluorouracil—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Cefixime—Headache—Sunitinib—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Cefixime—Leukopenia—Docetaxel—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Cefixime—Body temperature increased—Fluorouracil—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Cefixime—Eosinophilia—Doxorubicin—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Cefixime—Hypersensitivity—Irinotecan—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Cefixime—Convulsion—Docetaxel—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Cefixime—Nausea—Sunitinib—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Cefixime—Pancytopenia—Doxorubicin—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Cefixime—Renal failure—Epirubicin—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Cefixime—Jaundice—Epirubicin—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Cefixime—Urinary tract infection—Epirubicin—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Cefixime—Neutropenia—Doxorubicin—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Cefixime—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Cefixime—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Cefixime—Pruritus—Gemcitabine—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Cefixime—Diarrhoea—Irinotecan—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Cefixime—Agranulocytosis—Epirubicin—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Cefixime—Shock—Docetaxel—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Cefixime—Pruritus—Fluorouracil—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Cefixime—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Cefixime—Diarrhoea—Gemcitabine—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Cefixime—Renal failure—Doxorubicin—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Cefixime—Dizziness—Irinotecan—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Cefixime—Haemoglobin—Epirubicin—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Cefixime—Jaundice—Doxorubicin—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Cefixime—Urinary tract infection—Doxorubicin—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Cefixime—Haemorrhage—Epirubicin—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Cefixime—Hepatitis—Epirubicin—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Cefixime—Diarrhoea—Fluorouracil—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Cefixime—Vomiting—Irinotecan—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Cefixime—Dizziness—Fluorouracil—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Cefixime—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Cefixime—Rash—Irinotecan—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Cefixime—Dermatitis—Irinotecan—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Cefixime—Headache—Irinotecan—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Cefixime—Erythema multiforme—Epirubicin—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Cefixime—Vomiting—Gemcitabine—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Cefixime—Rash—Gemcitabine—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Cefixime—Dermatitis—Gemcitabine—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Cefixime—Haemoglobin—Doxorubicin—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Cefixime—Headache—Gemcitabine—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Cefixime—Vomiting—Fluorouracil—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Cefixime—Dyspepsia—Docetaxel—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Cefixime—Haemorrhage—Doxorubicin—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Cefixime—Hepatitis—Doxorubicin—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Cefixime—Rash—Fluorouracil—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Cefixime—Dermatitis—Fluorouracil—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Cefixime—Headache—Fluorouracil—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Cefixime—Nausea—Irinotecan—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Cefixime—Nausea—Gemcitabine—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Cefixime—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Cefixime—Nausea—Fluorouracil—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Cefixime—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Cefixime—Flatulence—Epirubicin—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Cefixime—Body temperature increased—Docetaxel—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Cefixime—Abdominal pain—Docetaxel—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Cefixime—Flatulence—Doxorubicin—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Cefixime—Leukopenia—Epirubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Cefixime—Hypersensitivity—Docetaxel—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Cefixime—Convulsion—Epirubicin—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Cefixime—Pruritus—Docetaxel—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Cefixime—Leukopenia—Doxorubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Cefixime—Diarrhoea—Docetaxel—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Cefixime—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Cefixime—Shock—Epirubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Cefixime—Convulsion—Doxorubicin—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Cefixime—Dizziness—Docetaxel—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Cefixime—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Cefixime—Vomiting—Docetaxel—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Cefixime—Rash—Docetaxel—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Cefixime—Dermatitis—Docetaxel—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Cefixime—Headache—Docetaxel—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Cefixime—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Cefixime—Shock—Doxorubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Cefixime—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Cefixime—Nausea—Docetaxel—pancreatic cancer	0.00098	0.00098	CcSEcCtD
Cefixime—Dyspepsia—Epirubicin—pancreatic cancer	0.00098	0.00098	CcSEcCtD
Cefixime—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00091	0.00091	CcSEcCtD
Cefixime—Dyspepsia—Doxorubicin—pancreatic cancer	0.000907	0.000907	CcSEcCtD
Cefixime—Urticaria—Epirubicin—pancreatic cancer	0.000884	0.000884	CcSEcCtD
Cefixime—Abdominal pain—Epirubicin—pancreatic cancer	0.00088	0.00088	CcSEcCtD
Cefixime—Body temperature increased—Epirubicin—pancreatic cancer	0.00088	0.00088	CcSEcCtD
Cefixime—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000842	0.000842	CcSEcCtD
Cefixime—Hypersensitivity—Epirubicin—pancreatic cancer	0.00082	0.00082	CcSEcCtD
Cefixime—Urticaria—Doxorubicin—pancreatic cancer	0.000818	0.000818	CcSEcCtD
Cefixime—Abdominal pain—Doxorubicin—pancreatic cancer	0.000814	0.000814	CcSEcCtD
Cefixime—Body temperature increased—Doxorubicin—pancreatic cancer	0.000814	0.000814	CcSEcCtD
Cefixime—Pruritus—Epirubicin—pancreatic cancer	0.000787	0.000787	CcSEcCtD
Cefixime—Diarrhoea—Epirubicin—pancreatic cancer	0.000762	0.000762	CcSEcCtD
Cefixime—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000759	0.000759	CcSEcCtD
Cefixime—Dizziness—Epirubicin—pancreatic cancer	0.000736	0.000736	CcSEcCtD
Cefixime—Pruritus—Doxorubicin—pancreatic cancer	0.000729	0.000729	CcSEcCtD
Cefixime—Vomiting—Epirubicin—pancreatic cancer	0.000708	0.000708	CcSEcCtD
Cefixime—Diarrhoea—Doxorubicin—pancreatic cancer	0.000705	0.000705	CcSEcCtD
Cefixime—Rash—Epirubicin—pancreatic cancer	0.000702	0.000702	CcSEcCtD
Cefixime—Dermatitis—Epirubicin—pancreatic cancer	0.000701	0.000701	CcSEcCtD
Cefixime—Headache—Epirubicin—pancreatic cancer	0.000697	0.000697	CcSEcCtD
Cefixime—Dizziness—Doxorubicin—pancreatic cancer	0.000681	0.000681	CcSEcCtD
Cefixime—Nausea—Epirubicin—pancreatic cancer	0.000661	0.000661	CcSEcCtD
Cefixime—Vomiting—Doxorubicin—pancreatic cancer	0.000655	0.000655	CcSEcCtD
Cefixime—Rash—Doxorubicin—pancreatic cancer	0.000649	0.000649	CcSEcCtD
Cefixime—Dermatitis—Doxorubicin—pancreatic cancer	0.000649	0.000649	CcSEcCtD
Cefixime—Headache—Doxorubicin—pancreatic cancer	0.000645	0.000645	CcSEcCtD
Cefixime—Nausea—Doxorubicin—pancreatic cancer	0.000612	0.000612	CcSEcCtD
